Publisher
Springer Science and Business Media LLC
Reference60 articles.
1. Benedict, R. H., DeLuca, J., Phillips, G., LaRocca, N., Hudson, L. D., & Rudick, R. (2017). Multiple sclerosis outcome assessments consortium. Validity of the symbol digit modalities test as a cognition performance outcome measure for multiple sclerosis. Multiple Sclerosis, 23(5), 721–733.
2. Bevan, C. J., & Cree, B. A. (2014). Disease, activity free status: A new end point for a new era in multiple sclerosis clinical research? Journal of the American Medical Assocation Neurology, 1(3), 269–270.
3. Biberacher, V., Schmidt, P., Keshavan, A., Boucard, C. C., Righart, R., Sämann, P., Preibisch, C., Fröbel, D., Aly, L., Hemmer, B., Zimmer, C., Henry, R. G., & Mühlau, M. (2016). Intra- and interscanner variability of magnetic resonance imaging based volumetry in multiple sclerosis. Neuroimage, 142, 188–197.
4. Bsteh, G., Feige, J., Ehling, R., Auer, M., Hegen, H., Di Pauli, F., Deisenhammer, F., Reindl, M., & Berger, T. (2017). Discontinuation of disease-modifying therapies in multiple sclerosis - Clinical outcome and prognostic factors. Multiple Sclerosis, 23(9), 1241–1241.
5. Capra, R., Cordioli, C., Rasia, S., Gallo, F., Signori, A., & Sormani, M. P. (2017). Assessing long-term prognosis improvement as a consequence of treatment pattern changes in MS. Multiple Sclerosis, 23(13), 1757–1761.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献